Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    10816186 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Comparison of the Incidence of Dyskinesia in Parkinson`s Disease Who Were Treated With Amantadine or Dopamine Agonist
Condition: Parkinson`s Disease
Intervention:
2 Completed Reducing Dyskinesia in Parkinson's Disease With Omega-3 Fatty Acids
Condition: Parkinson's Disease
Interventions: Drug: Docosahexaenoic Acid (DHA);   Drug: Placebo
3 Withdrawn Natural History of Levodopa-Induced Dyskinesia (LID)
Condition: Parkinson's Disease
Intervention: Drug: Levodopa (delivered intravenously)

Study has passed its completion date and status has not been verified in more than two years.